Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R (2019) Acromegaly. Nat Rev Dis Primers 5(1):20. Erratum in: Nat Rev Dis Primers 2019;5(1):72
Boguszewski CL (2020) Acromegaly: ‘You must know it to think of it’. Eur J Endocrinol 183(1):C1–C4
Article CAS PubMed Google Scholar
Kasuki L, Rocha PDS, Lamback EB, Gadelha MR (2019) Determinants of morbidities and mortality in acromegaly. Arch Endocrinol Metab 63(6):630–637
Article PubMed PubMed Central Google Scholar
Melmed S (2006) Medical progress: Acromegaly. N Engl J Med 355(24):2558–2573
Article CAS PubMed Google Scholar
Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’. Eur J Endocrinol 152(3):379–387
Article CAS PubMed Google Scholar
Shimon I, Jallad RS, Fleseriu M, Yedinak CG, Greenman Y, Bronstein MD (2015) Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors. Eur J Endocrinol 172(6):707–713
Article CAS PubMed Google Scholar
Ho RW, Huang HM, Ho JT (2015) The influence of pituitary adenoma size on vision and visual outcomes after trans-sphenoidal adenectomy: a report of 78 cases. J Korean Neurosurg Soc 57(1):23–31
Article CAS PubMed PubMed Central Google Scholar
Garibi J, Pomposo I, Villar G, Gaztambide S (2002) Giant pituitary adenomas: clinical characteristics and surgical results. Br J Neurosurg 16(2):133–139
Article CAS PubMed Google Scholar
Mortini P, Barzaghi R, Losa M, Boari N, Giovanelli M (2007) Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients. Neurosurgery 60(6):993–1002 discussion 1003-4
Symon L, Jakubowski J, Kendall B (1979) Surgical treatment of giant pituitary adenomas. J Neurol Neurosurg Psychiatry 42(11):973–982
Article CAS PubMed PubMed Central Google Scholar
Sinha S, Sharma BS (2010) Giant pituitary adenomas–an enigma revisited. Microsurgical treatment strategies and outcome in a series of 250 patients. Br J Neurosurg 24(1):31–39
Fernandez-Rodriguez E, Casanueva FF, Bernabeu I (2015) Update on prognostic factors in acromegaly: is a risk score possible? Pituitary 18(3):431–440
Article CAS PubMed Google Scholar
Lundin P, Edén Engström B, Karlsson FA, Burman P (1997) Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR. AJNR Am J Neuroradiol 18(4):765–772
CAS PubMed PubMed Central Google Scholar
Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M, Auriemma R, Diallo AM, Hulting AL, Ferone D, Hana V Jr, Filipponi S, Sievers C, Nogueira C, Fajardo-Montañana C, Carvalho D, Hana V, Stalla GK, Jaffrain-Réa ML, Delemer B, Colao A, Brue T, Neggers SJCMM, Zacharieva S, Chanson P, Beckers A (2017) Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) database. Endocr Relat Cancer 24(10):505–518
Article CAS PubMed PubMed Central Google Scholar
Bondanelli M, Ambrosio MR, degli Uberti EC (2001) Pathogenesis and prevalence of hypertension in acromegaly. Pituitary 4(4):239–249
Article CAS PubMed Google Scholar
Slagboom TNA, van Bunderen CC, De Vries R, Bisschop PH, Drent ML (2023) Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines. Pituitary 26(4):319–332
Article PubMed PubMed Central Google Scholar
González B, Vargas G, de Los Monteros ALE, Mendoza V, Mercado M (2018) Persistence of diabetes and hypertension after Multimodal Treatment of Acromegaly. J Clin Endocrinol Metab 103(6):2369–2375
Puig-Domingo M, Resmini E, Gomez-Anson B, Nicolau J, Mora M, Palomera E, Martí C, Halperin I, Webb SM (2010) Magnetic resonance imaging as a predictor of response to somatostatin analogs in acromegaly after surgical failure. J Clin Endocrinol Metab 95(11):4973–4978
Article CAS PubMed Google Scholar
Ghajar A, Jones PS, Guarda FJ, Faje A, Tritos NA, Miller KK, Swearingen B, Nachtigall LB (2020) Biochemical control in Acromegaly with Multimodality therapies: outcomes from a Pituitary Center and Changes over Time. J Clin Endocrinol Metab 105(3):e532–e543
Guo X, Zhang R, Zhang D, Wang Z, Gao L, Yao Y, Deng K, Bao X, Feng M, Xu Z, Yang Y, Lian W, Wang R, Ma W, Xing B (2022) Hyperprolactinemia and Hypopituitarism in Acromegaly and Effect of Pituitary surgery: long-term follow-up on 529 patients. Front Endocrinol (Lausanne) 12:807054
Rosendal C, Arlien-Søborg MC, Nielsen EH, Andersen MS, Feltoft CL, Klose M, Andreassen M, Bruun NH, Jørgensen JOL, Dal J (2024) Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study. Front Endocrinol (Lausanne) 15:1380436
Fleseriu M, Barkan A, Del Pilar Schneider M, Darhi Y, de Pierrefeu A, Ribeiro-Oliveira A Jr, Petersenn S, Neggers S, Melmed S (2022) Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States. Pituitary 25(2):296–307
Article PubMed PubMed Central Google Scholar
Raverot G, Jouanneau E, Trouillas J (2014) Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies. Eur J Endocrinol 170(4):R121–R132
Article CAS PubMed Google Scholar
Gondim JA, Almeida JP, Albuquerque LA, Gomes EF, Schops M (2014) Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach. World Neurosurg 82(1–2):e281–e290
Penner F, Prencipe N, Pennacchietti V, Pacca P, Cambria V, Garbossa D, Zenga F (2019) Super Giant Growth hormone-secreting Pituitary Adenoma in Young Woman: from ventricles to nose. World Neurosurg 122:544–548
Rahimli T, Hidayetov T, Yusifli Z, Memmedzade H, Rajabov T, Aghayev K (2021) Endoscopic Endonasal Approach to Giant Pituitary adenomas: Surgical outcomes and Review of the literature. World Neurosurg 149:e1043–e1055
Elshazly K, Kshettry VR, Farrell CJ, Nyquist G, Rosen M, Evans JJ (2018) Clinical outcomes after endoscopic endonasal resection of Giant Pituitary Adenomas. World Neurosurg 114:e447–e456
Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, Bonneville JF, Assaker R, Auger C, Brue T, Cornelius A, Dufour H, Jouanneau E, François P, Galland F, Mougel F, Chapuis F, Villeneuve L, Maurage CA, Figarella-Branger D, Raverot G (2013) members of HYPOPRONOS; Barlier A, Bernier M, Bonnet F, Borson-Chazot F, Brassier G, Caulet-Maugendre S, Chabre O, Chanson P, Cottier JF, Delemer B, Delgrange E, Di Tommaso L, Eimer S, Gaillard S, Jan M, Girard JJ, Lapras V, Loiseau H, Passagia JG, Patey M, Penfornis A, Poirier JY, Perrin G, Tabarin A. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126(1):123 – 35
Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB, Wass JA (1999) Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) 50(5):561–567
Article CAS PubMed Google Scholar
Shimon I, Cohen ZR, Ram Z, Hadani M (2001) Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48(6):1239–1243 discussion 1244-5
Koylu B, Firlatan B, Sendur SN, Oguz SH, Dagdelen S, Erbas T (2023) Giant growth hormone-secreting pituitary adenomas from the endocrinologist’s perspective. Endocrine 79(3):545–553
Article CAS PubMed Google Scholar
Chen M, Duan L, Miao H, Yu N, Yang S, Wang L, Gong F, Yao Y, Zhu H (2023) Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases. Pituitary 26(6):675–685
留言 (0)